Detail akcie ResMed online

Business Summary: ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Financial Summary: BRIEF: For the three months ended 30 September 2025, Resmed Inc revenues increased 9% to $1.34B. Net income increased 12% to $348.5M. Revenues reflect Sleep and Breathing Health segment increase of 10% to $1.17B, Residential Care Software segment increase of 6% to $166.1M. Net income benefited from Interest income (expense), net increase from $1.7M (expense) to $8.8M (income), Gain (loss) attributable to equity metho increase of 55% to $1.5M (income).